Hemp Revolution Research Case Underway

Nutrition News Hemp Revolution Cover

Hemp Revolution Is Well Underway

Ongoing research into the complex compounds found in cannabis are adding to the knowledge base  Dr. Daniele Piomelli offers testimony on Medical Cannabis

Dr. Daniele Piomelli, Editor-in-Chief of Cannabis and Cannabinoid Research, provided testimony on the science behind Cannabis research at a Senate Judiciary Committee, and Subcommittee on Crime and Terrorism, hearing on “Researching the Potential Medical Benefits and Risks of Marijuana.”

The hearing was held on July 13, 2016, and was a timely discussion about researching the potential medical benefits of the Cannabis plant and its cannabinoid chemical components.Testimony was offered to the Subcommittee on Crime and Terrorism. I think that says it all when it comes to the dogged reluctance to putting the research we already have into wide spread medical use.

The hearing also addressed further removal of unnecessary barriers to research on cannabis and cannabinoids; especially, cannabidiol in the United States, where we like to think of ourselves as exceptional. An in the case of adopting medicinal cannabis, we are exceptionally resistant to health and wellness.


The Glycaemic Outcomes Of Cinnamon

Cinnamon Stick and Powder

The Glycaemic Outcomes Of Cinnamon, A Review Of The Experimental Evidence And Clinical Trials

Arjuna B. Medagama Email author Nutrition Journal201514:108 DOI: 10.1186/s12937-015-0098-9 ©  Medagama. 2015

Recent estimates show that over 80 % of people living in developing countries depend on Complimentary Alternative Medicine for treatment of health conditions [9]. In the United States an increase of 380 % is seen in the use of herbal remedies [13]. The economic burden of CAMs is substantial, with the UK population in 2001 having spent an estimated 340 million pounds on CAMs [14]. More recently in 2013, Herman estimates the cost of Complementary and Integrative Medicine (CIM) in the US to be 34 billion dollars [15].

Integrative medicine is a new discipline of medicine that combines conventional medicine with evidence-based complementary medicines. Patients with diabetes are increasingly eager to be part of their disease management and keen to try out integrative strategies that involve lifestyle changes and self management [16].

Food as medicine is still the quickest direct route to wellness. Now we’re just going to prove it to ourselves all over again.

→  Read full article

New Cannabis and Cannabinoid Research Journal

25 June 2015 Mary Ann Liebert, Inc., Publishers

“…carefully prescribed medical use of marijuana may in fact be appropriate and we should follow the science as opposed to ideology on this issue,”

Mary Ann Liebert, publisher of the newly launched peer-reviewed open access journal Cannabis and Cannabinoid Research, strongly supports President Obama’s statement that “…carefully prescribed medical use of marijuana may in fact be appropriate and we should follow the science as opposed to ideology on this issue,” when asked about a pending Senate bill seeking to change federal law regarding state-legalized medical marijuana programs.

Cannabis and Cannabinoid Research, a fully open access journal will be the authoritative source for research, discussion, and debate. Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/) will publish the Journal under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.

Cannabis and Cannabinoid Research will publish fully peer-reviewed, evidence-based original articles, review articles, and perspectives on cannabis, cannabinoids, and the endocannabinoid system.

The Journal will publish a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies.

An interdisciplinary community including pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, physicians, and other healthcare practitioners, addiction specialists, and regulators and policymakers are invited to participate in this new open access resource.

Topics in Cannabis and Cannabinoid Research will include: Biochemical process of the endocannabinoid system * Cannabinoid receptors and signaling

* Pharmaceuticals based on cannabis and cannabinoids * Optimal dosing and drug delivery

* Short- and long-term effects on the brain and behavior * Toxicological studies

* Analgesic effects, including neuropathic pain and chronic nerve injury

* Neurological disorders, including epilepsy, multiple sclerosis, and glaucoma * Use of cannabis as antinauseants and antispasmodics

* Immune function and chronic inflammation, including HIV * Cancer and cancer-related treatment

* Screening and assessment for marijuana misuse and addiction * Social, behavioral, and public health impact

* Ethics, regulation, legalization, and public policy.

Cannabis and Cannabinoid Research (http://www.liebertpub.com/can) will build a central forum and repository for peer-reviewed open access papers, as more high-quality research is needed to move the field forward.

“Cannabis research and its applications for therapy will create new challenges as its promise is evaluated,” says Mary Ann Liebert, founder, President, and CEO of the company that bears her name.

“Scientists in the lab and those on the front lines of patient care now have an important new educational forum. Cannabis and Cannabinoid Research (http://www.liebertpub.com/can, which is fully open access, will be the Journal of record.”


Health Habits Of Dietary Supplement Users


Health habits and other characteristics

of dietary supplement users: A review

It’s always a welcome development to see a story that backs up what the majority of Americans already know. Taking nutritional supplements is part of a healthier lifestyle and in fact, healthier outcomes.  That’s quite a contrast to the negative press appearing regularly about  how  nutritional supplements are worthless or even dangerous. Just keep taking big pharma’s  answers to  all our health problems. Talk about not being clear on the health care concept.  I guess two thirds of adult Americans must be wrong.

Published: 6 February 2014

Annette Dickinson and Douglas MacKay

Abstract (provisional)


Dietary supplements are used by half to two-thirds of American adults, and the evidence suggests that this usage is one component of a larger effort to develop a healthier lifestyle. Dietary supplement users tend on average to be better educated and to have somewhat higher incomes than nonusers, and these factors may contribute to their health-consciousness.

Woman taking vitaminsDietary supplement use also tends to be more prevalent among women than among men, and the prevalence of use increases with age in both men and women. Numerous surveys document that users of dietary supplements are significantly more likely than nonusers to have somewhat better dietary patterns, exercise regularly, maintain a healthy weight, and avoid tobacco products.

While supplement users tend to have better diets than nonusers, the differences are relatively small, their diets have some substantial nutrient shortfalls, and their supplement use has been shown to improve the adequacy of nutrient intakes. Overall, the evidence suggests that users of dietary supplements are seeking wellness and are consciously adopting a variety of lifestyle habits that they consider to contribute to healthy living.


The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

Author Affiliations

Email: Annette Dickinson annettedickinson@comcast.net – Douglas MacKay dmackay@crnusa.org



American Herbal Pharmacopoeia Releases Cannabis Monograph

Cannabis Plants

SCOTTS VALLEY, Calif.— The American Herbal Pharmacopoeia (AHP) finalized its cannabis monograph to establish standards for the botanical’s identity, purity, analysis, and quality. The monograph also provides information of cannabis’ cultivation, storage and preparation.

In an historic move, the American Herbal Pharmacopoeia (AHP) released the first installation of a two-part Cannabis monograph yesterday that classifies cannabis (marijuana) as a botanical medicine, alongside many other widely accepted Complementary and Alternative Medicines. Written and reviewed by the world’s leading experts, the Cannabis monograph brings together an authoritative compendium of scientific data, including long-awaited standards for the plant’s identity, purity, quality, and botanical properties. The monograph provides a foundation for health care professionals to integrate cannabis therapy into their practices on the basis of a full scientific understanding of the plant, its constituent components, and its biologic effects.

“Cannabis has been used medicinally pretty much throughout the entire timeline of written history, and from archeological evidence, far beyond into antiquity. Virtually every culture who had access to it either from local flora or trade, which was widespread, used it medicinally and recreationally,” said Roy Upton, AHP president.

Set to release by the end of the year, the monograph will offer expert information for growers, caregivers, patients, practitioners, analytical labs, state regulators and researchers. In the future, AHP will publish a Therapeutic Compendium comprehensive review on the plant.

AHP medical director Aviva Romm, M.D., initially suggested AHP pursue a cannabis monograph after seeing patients benefit from the botanical. Since then, 20 states have recognized the botanical’s medical utility to pass medical marijuana laws, but no universal standards have been adopted.

In January, American Herbal Products Association‘s (AHPA) Cannabis Committee drafted regulatory recommendations for medical marijuana dispensing in three states; the committee is a partnership with Americans for Safe Access (ASA), which expressed the need for widespread botanical benchmarks.

“The AHP monograph creates much needed quality assurance standards for States that have medical access laws,” said Steph Sherer, executive director of ASA. “The adoption of these standards will create confidence in the quality and reliability of cannabis therapies for patients and their physicians.”

AHP developed the monograph in collaboration with University of Mississippi, with help from Mahmoud ElSohly, Ph.D., professor of pharmaceutics and cannabis botanical expert.

Further Reading

U.S. Patent on cannabinoids as anti-oxidants and neuro-protectants

Study shows whole herbal cannabis causes cells becoming cancerous to self destruct

Synthetic, fossil fuel base Marinol inferior to natural cannabis

Cancer cure from using cannabis

Juicing cannabis leaves to treat illness

Why The War on Drugs has Failed – An infographic by Paul at Ocean Recovery Centre.

This infographic explains why the war on drugs has failed, and possible alternative policies that could be used to replace the War on Drugs.

As a matter of public health, it doesn’t help to bury one’s head in the sand and ignore solutions. We can ill afford to waste the resources at hand. Changing a failed public policy is a good first step.

Superfoods cover image

Play The Is It Healthy Game!

Read Nutrition News

Making Healthy Choices Easier Than You Think

You have Successfully Subscribed!